IP Library Granted Patent US 7,125,886
Granted Patent B2
US 7,125,886 · App. 10/857,108 · Granted Oct 24, 2006

5-HT3 receptor antagonists and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,886
App. No.
10/857,108
Granted
Oct 24, 2006
Kind
B2
Abstract

The subject invention provides useful and novel 5-HT3 antagonists. The subject invention also provides methods for synthesizing the compounds of invention. The invention also provides methods for the treatment of irritable bowel syndrome and other such conditions.

Claims (56)

1. The compound, wherein said compound has the following structure, or a salt of a compound having the following structure:

wherein,

X=N or CH; and

R=lower alkyl substituted with OH or NH 2 .

2. The compound, according to claim 1 , having the following formula:

wherein

X=N or CH; and

R=lower alkyl substituted with OH or NH 2 .

3. The compound, according to claim 1 , wherein said compound has the following structure, or a salt of a compound having the following structure:

wherein

X=N or CH;

Y=(CH 2 ) n ;

n is 0; and

R=lower alkyl optionally substituted with OH or NH 2 .

4. The compound, according to claim 3 , having the following structure:

wherein

X=N or CH;

Y=(CH 2 ) n ;

n is 0; and

R=lower alkyl optionally substituted with OH or NH 2 .

5. The compound, according to claim 1 , wherein said compound has the following structure, or a salt of a compound having the following structure:

wherein

X=N or CH; and

R=lower alkyl optionally substituted with OH or NH 2 .

6. The compound, according to claim 5 , having the following structure:

wherein

X=N or CH; and

R=lower alkyl optionally substituted with OH or NH 2 .

7. The pharmaceutical composition, comprising a compound, or salt thereof, wherein said compound has the following structure:

wherein

X=N or CH; and

R=lower alkyl substituted with OH or NH 2 .

8. The composition, according to claim 7 , comprising a compound having the following structure:

wherein

X=N or CH; and

R=lower alkyl substituted with OH or NH 2 .

9. The composition, according to claim 7 , comprising a compound or salt thereof, wherein said compound has the following structure:

wherein

X=N or CH;

Y=(CH 2 ) n ;

n is 0; and

R=lower alkyl optionally substituted with OH or NH 2 .

10. The composition, according to claim 7 , comprising a compound having the following structure:

wherein

X=N or CH;

Y=(CH 2 ) n ;

n is 0; and

R=lower alkyl optionally substituted with OH or NH 2 .

11. The composition, according to claim 1 , comprising a compound, or salt thereof, wherein said compound has having the following structure:

wherein

X=N or CH; and

R=lower alkyl optionally substituted with OH or NH 2 .

12. The composition, according to claim 11 , comprising a compound having the following structure:

wherein

X=N or CH; and

R=lower alkyl optionally substituted with OH or NH 2 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2007
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 020024/0545 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2005
From: ZHANG, XIAOMING; PFISTER, JURG R.; BECKER, CYRUS; DRUZGALA, PASCAL
To: ARYX THERAPEUTICS
Reel/Frame 016444/0066 →